findmyKOL

Peter Lewitt, MD

Enriched profile

Professor of Neurology and Pharmacology, Sastry Foundation Endowed Chair in Parkinson Disease Research; Director, Parkinson's Disease and Movement Disorders Program at Henry Ford Hospital · Wayne State University School of Medicine

ORCIDNPI
Region🇺🇸 West Bloomfield, MI · Midwest · United StatesSpecialtyNeurologyFocusParkinson's Disease Mechanisms and Treatments+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1990–2006

Peter Lewitt is Professor of Neurology and Pharmacology, Sastry Foundation Endowed Chair in Parkinson Disease Research; Director, Parkinson's Disease and Movement Disorders Program at Henry Ford Hospital at Wayne State University School of Medicine. OpenAlex indexes 312 publications with 22,843 citations (h-index 61); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Neurology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Peter A. LeWitt, MD, is Professor of Neurology and Pharmacology, Sastry Foundation Endowed Chair in Parkinson Disease Research at Wayne State University School of Medicine, Department of Neurology. The public record shows 312 publications with 22,843 citations (h-index 61), centered on Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Botulinum Toxin and Related Neurological Disorders. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 23 companies, 3 NIH-funded awards (1990–2006).

  • Most recent indexed publication: 2026 · Brain
  • Top research focus: Parkinson's Disease Mechanisms and Treatments
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 23 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Parkinson's Disease4 trialsGait Disorders, Neurologic1 trialEssential Tremor1 trialTremor1 trialAlzheimer's / Dementia

Research focus

OpenAlex concept fingerprint
Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsBotulinum Toxin and Related Neurological DisordersGenetic Neurodegenerative DiseasesAlzheimer's disease research and treatments

Drugs & molecules

across trials, industry payments and publications
Nourianzgeneric · IstradefyllineClinical trialsIndustry payments18Publications1Inbrijageneric · LevodopaClinical trialsIndustry payments9Publications6Apokyngeneric · ApomorphineClinical trialsIndustry payments6Publications2

Works with

trial sponsors and companies reporting payments
MDD US Operations, LLCClinical trialsIndustry payments98Amneal Pharmaceuticals LLCClinical trialsIndustry payments24Kyowa Kirin, Inc.Clinical trialsIndustry payments19

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
312publications

Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.

22,843citations

Total citations across indexed works.

61h-index

Hirsch index (OpenAlex). i10-index 171.

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials
23companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
3NIH grants · 1990–2006

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

23 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    91.5%
    Aromatic Amino Acid Decarboxylation Inhibitor53.2%
    Carbidopa-Levodopa85%Carbidopa-Levodopa Er9%Rytary6%
    Part D<11 patients
    Atypical Antipsychotic6.8%
    Quetiapine Fumarate100%
    Part D<11 patients
  • Musculoskeletal

    4.3%
    gamma-Aminobutyric Acid-ergic Agonist4.3%
    Baclofen100%
    Part D<11 patients
  • Cardiovascular

    4.3%
    Beta blocker4.3%
    Propranolol Hcl Er100%
    Part D<11 patients
Where care is delivered (Part B)82.6% facility · 17.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

3 NIH research awards on record, funded 19902006 per NIH RePORTER. The latest:

6 more award records behind the reveal.Reveal →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/peter-lewitt-1025ba16

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Peter-Lewitt

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • Doximity

    doximity.com/pub/peter-lewitt-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com
2 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
3 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Director

    Parkinson's Disease and Movement Disorders Program, Henry Ford Hospital, West Bloomfield/Detroit, MI

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →henryford.com

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.